Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 03, 2016 ) About Biosimilars
Biosimilars or follow-on biologics are generic versions of the biopharmaceutical products. These are developed following the patent expiry of an original molecule. Biosimilars have the same biological properties as original drugs and target the same diseases. They have many similarities but are not identical to the reference biopharmaceutical product.
Technavios analysts forecast the spending on the global monoclonal antibody (mAb) biosimilars market to grow at a CAGR of 4-7% during the period 2015-2020.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=825438
Covered in this report The report covers the present scenario and the growth prospects of the global monoclonal antibody (mAb) biosimilars market 2016-2020. To calculate the market size, the report considers the report considers the revenue generated from the sales of mAbs. The report also considers the revenues generated from the sales of drugs that are expected to be launched during the forecast period.
The market is divided into the following segments based on geography: Europe Asia ROW
Technavio's report, Global Monoclonal Antibody (mAb) Biosimilars Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html
Table of Content
PART 01: Executive summary Highlights PART 02: Scope of the report Market overview Top-vendor offerings Assumptions PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights Biosimilars: Overview Comparative analysis of generic small molecules and biosimilars Biosimilars market opportunities Challenges for new entrants Bio-betters PART 05: Pipeline portfolio PART 06: Market landscape Market overview Five forces analysis PART 07: Market segmentation by application Global chronic and autoimmune diseases mAb biosimilars market Global oncology mAb biosimilars market PART 08: Geographical segmentation Global mAb biosimilars market by geographical segmentation 2015-2020 mAb biosimilars market in Europe mAb biosimilars market in Asia mAb biosimilars market in rest of the world
Contact Us:
Mr. Nachiket Albany NY, United States - 12207 Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free) Email: sales@researchmoz.us Follow us on LinkedIn at: http://bit.ly/1TBmnVG Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|